Evidence map›Paper›PMID 24594709›Full record

ArticlePloS one2014

Loss of polycystin-1 inhibits Bicc1 expression during mouse development.

Peiwen Lian, Ao Li, Yuan Li, Haichao Liu, Dan Liang, Bo Hu, De Lin, Tang Jiang, Gilbert Moeckel, Dahui Qin and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Modeling congenital kidney diseases inDisease models & mechanisms · 2019
    Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Peiwen LianDivision of Translational Cancer Research and Therapy, State Key Laboratory of Molecular Oncology, Cancer Hospital and Institute, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; Department of Medicine, Vanderbilt University, Nashville, Tennessee, United States of America.
Ao LiDivision of Translational Cancer Research and Therapy, State Key Laboratory of Molecular Oncology, Cancer Hospital and Institute, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; Department of Medicine, Vanderbilt University, Nashville, Tennessee, United States of America.
Yuan LiDivision of Translational Cancer Research and Therapy, State Key Laboratory of Molecular Oncology, Cancer Hospital and Institute, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Haichao LiuDivision of Translational Cancer Research and Therapy, State Key Laboratory of Molecular Oncology, Cancer Hospital and Institute, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Dan LiangDepartment of Medicine, Vanderbilt University, Nashville, Tennessee, United States of America.
Bo HuDepartment of Medicine, Vanderbilt University, Nashville, Tennessee, United States of America.
De LinDepartment of Biochemistry, Vanderbilt University, Nashville, Tennessee, United States of America.
Tang JiangDepartment of Medicine, First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
Gilbert MoeckelDepartment of Pathology, Yale University School of Medicine, New Haven, Connecticut, United States of America.
Dahui QinDepartment of Pathology, Moffitt Cancer Center, Tampa, Florida, United States of America.
Guanqing WuDivision of Translational Cancer Research and Therapy, State Key Laboratory of Molecular Oncology, Cancer Hospital and Institute, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China; Department of Medicine, Vanderbilt University, Nashville, Tennessee, United States of America; Department of Cell & Developmental Biology, Vanderbilt University, Nashville, Tennessee, United States of America.
Vanderbilt University · USChinese Academy of Medical Sciences & Peking Union Medical College · CNMoffitt Cancer Center · USSun Yat-sen University · CNYale University · US

Funding

NCRR NIH HHS RR033682
6 · The paper itself

Abstract

Bicc1 is a mouse homologue of Drosophila Bicaudal-C (dBic-C), which encodes an RNA-binding protein. Orthologs of dBic-C have been identified in many species, from C. elegans to humans. Bicc1-mutant mice exhibit a cystic phenotype in the kidney that is very similar to human polycystic kidney disease. Even though many studies have explored the gene characteristics and its functions in multiple species, the developmental profile of the Bicc1 gene product (Bicc1) in mammal has not yet been completely characterized. To this end, we generated a polyclonal antibody against Bicc1 and examined its spatial and temporal expression patterns during mouse embryogenesis and organogenesis. Our results demonstrated that Bicc1 starts to be expressed in the neural tube as early as embryonic day (E) 8.5 and is widely expressed in epithelial derivatives including the gut and hepatic cells at E10.5, and the pulmonary bronchi at E11.5. In mouse kidney development, Bicc1 appears in the early ureteric bud and mesonephric tubules at E11.5 and is also expressed in the metanephros at the same stage. During postnatal kidney development, Bicc1 expression gradually expands from the cortical to the medullary and papillary regions, and it is highly expressed in the proximal tubules. In addition, we discovered that loss of the Pkd1 gene product, polycystin-1 (PC1), whose mutation causes human autosomal dominant polycystic kidney disease (ADPKD), downregulates Bicc1 expression in vitro and in vivo. Our findings demonstrate that Bicc1 is developmentally regulated and reveal a new molecular link between Bicc1 and Pkd1.

Indexed as

AnimalsBase SequenceBlotting, WesternCells, CulturedDNA PrimersDown-RegulationImmune SeraKidneyMiceMice, KnockoutMice, Mutant StrainsPolymerase Chain ReactionRNA-Binding ProteinsTRPP Cation ChannelsBicc1 protein, mouseDNA PrimersImmune SeraRNA-Binding ProteinsTRPP Cation Channels

Identifiers

PMID24594709
PMCPMC3940423
OpenAlexW1978569216

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.